Natera is a Texas-based diagnostics company specializing in genetic testing services and employs 3,282 people. Its offerings include non-invasive prenatal testing and a cloud-based software platform for lab customers.
John Fesko sold 17,806 shares of NTRA on 20 January at $234.74 per share, worth a total of $4.2M. They now own 177,591 NTRA shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.